RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재후보

      Effect of Osteotropic Agents on the Expression of RANKL and OPG in Saos-2 Cells

      한글로보기

      https://www.riss.kr/link?id=A30034459

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Various osteotropic agents that influence bone resorption are known to act primarily via osteoblasts/stromal cells. Recently, receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin (OPG) have been suggested to be key molecules that regulate osteoclast differentiation and activation. RANKL induces osteoclastogenesis and activates mature osteoclasts while OPG acts as a physiologic inhibtor of RANKL. It is conceivable, therefore, that change in RANKL and OPG expression in osteoblasts/stromal cells affect their ability to support osteoclast formation, activity and survival. In this study, we examined the effects of several osteotropic agents on RANKL and OPG mRAN expression in Saos-2 human osteoblastic cells. Cells were exposed to parathyroid hormone (PYH, 10^-8M), 1,25-dihydroxyvitamin D_3 (1,25(OH)_2D_3, 10^-8M), dexamethasone (10^-8M), interleukin-1β (IL-1β, 5ng/ml), tumor necrosis factor-α (TNF-α, 5ng/ml), transforming growth factor-β (TNF-β, 5ng/ml), or insulin-like growth factor-I (IGF-I, 10ng/ml) for 2, 4, 8, and 24h, and mRNA levels were analyzed by semi-quantitative reverse transcription-polymerase chain reaction. All the tested osteotropic agents more or less regulated both RANKL and OPG mRNA level during the examined period. RaNKL/OPG ratio was up-regulated by PTH, 1,25(OH)_2D_3, dexamethasone, TGF-β, IGF-I, and increased RANKL/OPG ratio was maintained up to 24h. IL-1β and TNF-α transiently they greatlhy decreased RANKL/OPG ratio. These results showed that RANKL and OPG could be potential targets for bone resorption regulation by osteotropic hormenes, cytokines, and growth factors. However, regulatory patterns were not alvays coincident with in vivo or in vitro effects on osteoclastogenesis, implying that RANKL and OPG are not the sole mediators of their action.
      번역하기

      Various osteotropic agents that influence bone resorption are known to act primarily via osteoblasts/stromal cells. Recently, receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin (OPG) have been suggested to be key molecules that...

      Various osteotropic agents that influence bone resorption are known to act primarily via osteoblasts/stromal cells. Recently, receptor activator of nuclear factor-kB ligand (RANKL) and osteoprotegerin (OPG) have been suggested to be key molecules that regulate osteoclast differentiation and activation. RANKL induces osteoclastogenesis and activates mature osteoclasts while OPG acts as a physiologic inhibtor of RANKL. It is conceivable, therefore, that change in RANKL and OPG expression in osteoblasts/stromal cells affect their ability to support osteoclast formation, activity and survival. In this study, we examined the effects of several osteotropic agents on RANKL and OPG mRAN expression in Saos-2 human osteoblastic cells. Cells were exposed to parathyroid hormone (PYH, 10^-8M), 1,25-dihydroxyvitamin D_3 (1,25(OH)_2D_3, 10^-8M), dexamethasone (10^-8M), interleukin-1β (IL-1β, 5ng/ml), tumor necrosis factor-α (TNF-α, 5ng/ml), transforming growth factor-β (TNF-β, 5ng/ml), or insulin-like growth factor-I (IGF-I, 10ng/ml) for 2, 4, 8, and 24h, and mRNA levels were analyzed by semi-quantitative reverse transcription-polymerase chain reaction. All the tested osteotropic agents more or less regulated both RANKL and OPG mRNA level during the examined period. RaNKL/OPG ratio was up-regulated by PTH, 1,25(OH)_2D_3, dexamethasone, TGF-β, IGF-I, and increased RANKL/OPG ratio was maintained up to 24h. IL-1β and TNF-α transiently they greatlhy decreased RANKL/OPG ratio. These results showed that RANKL and OPG could be potential targets for bone resorption regulation by osteotropic hormenes, cytokines, and growth factors. However, regulatory patterns were not alvays coincident with in vivo or in vitro effects on osteoclastogenesis, implying that RANKL and OPG are not the sole mediators of their action.

      더보기

      동일학술지(권/호) 다른 논문

      동일학술지 더보기

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼